events
News and Community
Content by Category
Artificial Intelligence in Health Tech
Medical Cloud Computing
Patient Engagement
EHR/EMR
Telehealth
Our Network
IT Tech News
CXO Insiders
Rev Tech News
Fin Tech News
HR Tech News
Client Papers
Soc News
Martech-News
events
News and Community
Content by Category
Artificial Intelligence in Health Tech
Medical Cloud Computing
Patient Engagement
EHR/EMR
Telehealth
Our Network
IT Tech News
CXO Insiders
Rev Tech News
Fin Tech News
HR Tech News
Client Papers
Soc News
Martech-News
Search
Login
events
News and Community
Content by Category
Artificial Intelligence in Health Tech
Medical Cloud Computing
Patient Engagement
EHR/EMR
Telehealth
Our Network
IT Tech News
CXO Insiders
Rev Tech News
Fin Tech News
HR Tech News
Client Papers
Soc News
Martech-News
events
News and Community
Content by Category
Artificial Intelligence in Health Tech
Medical Cloud Computing
Patient Engagement
EHR/EMR
Telehealth
Our Network
IT Tech News
CXO Insiders
Rev Tech News
Fin Tech News
HR Tech News
Client Papers
Soc News
Martech-News
Login
News and Community
Molecular Diagnostics Services Program
,
Molecular Residual Disease
,
Muscle-invasive Bladder Cancer
,
Truemrd Monitoring Test
,
Veracyte
,
Whole-genome Sequencing
May 18, 2026
Veracyte’s TrueMRD Monitoring Test Secures Vital Medicare Coverage in Muscle-Invasive Bladder Cancer
Biotech Leadership
,
Diagnostics Innovation
,
Healthcare Innovation
,
Healthcare Technology Leadership
,
Kevin Haas
,
Life Sciences Technology
,
Precision Medicine
,
Veracyte
March 18, 2026
Veracyte Appoints Kevin Haas as Chief Development and Technology Officer
Load More